DRUG · Mapped RxNorm record
Raltegravir
Normalized identity: raltegravirView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Advanced Neuroimaging Evaluation of CNS Changes Associated With Efavirenz Therapy Switch to an Raltegravir-based Regimen
NCT01978743
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedAdvanced Neuroimaging Evaluation of CNS Changes Associated With Efavirenz Therapy Switch to an Raltegravir-based Regimen
Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
HIVunresolved
HIV-associated Neurocognitive Disorderunresolved
Neurotoxicityverified · MONDO: toxic encephalopathy
Interventions
RaltegravirDRUG · verified · RxNorm: raltegravir
Sponsors & collaborators
Massachusetts General Hospitallead sponsor
Merck Sharp & Dohme LLCcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01978743 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.